NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

Trump to Launch Federal Research on Psychedelic Drug Ibogaine for PTSD

Trump plans to boost research on ibogaine for PTSD in veterans, despite safety concerns and its illegal status in the US.

Trump to Launch Federal Research on Psychedelic Drug Ibogaine for PTSD
"Ibogaine is the primary psychoactive component of the iboga plant." Credit: Rachel Nuwer/National Geographic
Already have an account? Sign in.
04/16/2026 · 12:51 PM
PBM
/ Read more

Feed↓

Akari Therapeutics Strengthens Balance Sheet and Prepares Phase 1 as Maxim Raises Rating to Buy
07/20/2026 · 1:13 PM

Akari Therapeutics Strengthens Balance Sheet and Prepares Phase 1 as Maxim Raises Rating to Buy

Backed by promising Trop2 ADC preclinical data, new financing, and strong ADC market momentum.

/ Subscriber only
Magnolia Oil & Gas Acquires WildFire Energy in $4.06 Billion Deal to Expand South Texas Footprint
Featured/ 07/20/2026 · 12:47 PM

Magnolia Oil & Gas Acquires WildFire Energy in $4.06 Billion Deal to Expand South Texas Footprint

The deal adds over 810,000 net acres, boosts production by 53,000 boe/d, and includes key infrastructure assets.

/ Subscriber only
RBC Bullish on Nuvation Bio as Safusidenib Delivers Durable Responses in Glioma with New Phase 3 and Phase 2 Studies
07/20/2026 · 12:18 PM

RBC Bullish on Nuvation Bio as Safusidenib Delivers Durable Responses in Glioma with New Phase 3 and Phase 2 Studies

Nuvation Bio reports strong long-term Phase 2 data for safusidenib (52% ORR, 79% PFS) and announces new Phase 3 and Phase 2 studies in IDH1-mutant glioma.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe